InvestorsHub Logo

biomaven0

05/27/12 9:18 PM

#142752 RE: vinmantoo #142751

The idea that one could look at a person's genome and make realistic predictions about their health prospects and the likelihood any of a vast array of different diseases was really sold in the early days of genome sequencing, but I always scoffed at the idea.



Well the SNP-based version has not worked out. But I'm guessing the full-sequence version has a better shot in a decade or two. Commonalities between identical twins raised apart of course provide the limit to which this project could ultimately succeed.

Peter

genisi

05/28/12 5:14 AM

#142756 RE: vinmantoo #142751

One needs a secondary terminology to describe the effect on protein function or activity.

One such terminology you find in the literature is non- synonymous and synonymous: nsSNP is a genetic code change that results in a different amino acid vs. sSNP where it doesn't alter the amino acid residue sequence.

DewDiligence

05/28/12 11:34 AM

#142766 RE: vinmantoo #142751

…there were some really wild statements about predictive powers that are obviously not coming true.

When reading your post, I thought of Kari Stefansson, founder of DeCode Genetics. Had Stefansson’s hypothesis about the common diseases of man been well founded, DeCode probably wouldn’t have gone bankrupt after burning through hundreds of millions of dollars.

jellybean

05/29/12 12:53 PM

#142828 RE: vinmantoo #142751

There are examples of single base changes which keep the primary amino acid sequence the same, yet alter the protein activity.



Really? How does that work? can you name one example?